SARS-CoV-2 nsp16 Methyltransferase

SARS-CoV-2 nsp16 Methyltransferase

CAT N°: 31816
Price:

759.00 645.15

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped positive-stranded RNA virus and the causative agent of COVID-19, a primarily respiratory illness characterized by fever, cough, and shortness of breath that can lead to life-threatening complications.{53462,53459,53461,55257,55258} The SARS-CoV-2 genome contains approximately 30 kilobases and 14 open reading frames (ORFs) that encode four structural proteins: spike, envelope, membrane, and nucleocapsid, as well as 16 non-structural proteins and 9 accessory factors.{57176} SARS-CoV-2 nsp16 methyltransferase is a 2′-O-methyltransferase (2′-O-MTase) and has a role in 5′-end capping of viral mRNAs.{52793,52794} In coronaviruses, nsp16 forms a complex with nsp10 to methylate nascent mRNAs at the ribose 2′-O position, creating a Cap-1 structure that facilitates increased translation of viral mRNAs and reduced innate immune recognition by the host cell.{52794,52795} Deficiency of nsp16 in the related virus SARS-CoV reduces viral RNA synthesis by approximately 10-fold in vitro, and mutations in the nsp16 KDKE catalytic tetrad in mouse-adapted SARS-CoV attenuate the virus in vivo.{52794,52796} An nsp10-derived peptide inhibitor of the nsp16/nsp10 complex increases survival in a mouse model of infection with the coronavirus mouse hepatitis virus (MHV).{52795} Cayman’s SARS-CoV-2 nsp16 Methyltransferase protein consists of 299 amino acids and has a calculated molecular weight of 33.46 kDa.

We also advise you

TAF 10 Peptide

TAF 10 Peptide

TAF10 is one of many protein factors or coactivators associated with RNA polymerase II activity.{16903} One vial of this peptide...

€191.00
View